Skip to content

3'-[2-(2-methyl-5-nitroimidazol-1-yl)ethyl]spiro[adamantane-2,5'-imidazolidine]-2',4'-dione

C18H23N5O4 — CID 54526719

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPAC3'-[2-(2-methyl-5-nitroimidazol-1-yl)ethyl]spiro[adamantane-2,5'-imidazolidine]-2',4'-dione
SMILESCc1ncc([N+](=O)[O-])n1CCN1C(=O)NC2(C1=O)C1CC3CC(C1)CC2C3
InChIInChI=1S/C18H23N5O4/c1-10-19-9-15(23(26)27)21(10)2-3-22-16(24)18(20-17(22)25)13-5-11-4-12(7-13)8-14(18)6-11/h9,11-14H,2-8H2,1H3,(H,20,25)
InChIKeyYTQDCUMODKDTGZ-UHFFFAOYSA-N
MW373.41 g/mol
LogP1.85
Rot. Bonds4

About 3'-[2-(2-methyl-5-nitroimidazol-1-yl)ethyl]spiro[adamantane-2,5'-imidazolidine]-2',4'-dione

3'-[2-(2-methyl-5-nitroimidazol-1-yl)ethyl]spiro[adamantane-2,5'-imidazolidine]-2',4'-dione (PubChem CID 54526719) has the molecular formula C18H23N5O4 and a molecular weight of 373.41 g/mol. Its IUPAC name is 3'-[2-(2-methyl-5-nitroimidazol-1-yl)ethyl]spiro[adamantane-2,5'-imidazolidine]-2',4'-dione.

Molecular Properties

Compound Name3'-[2-(2-methyl-5-nitroimidazol-1-yl)ethyl]spiro[adamantane-2,5'-imidazolidine]-2',4'-dione
PubChem CID54526719
Molecular FormulaC18H23N5O4
Molecular Weight373.41 g/mol
Exact Mass373.18
IUPAC Name3'-[2-(2-methyl-5-nitroimidazol-1-yl)ethyl]spiro[adamantane-2,5'-imidazolidine]-2',4'-dione
SMILESCc1ncc([N+](=O)[O-])n1CCN1C(=O)NC2(C1=O)C1CC3CC(C1)CC2C3
InChIInChI=1S/C18H23N5O4/c1-10-19-9-15(23(26)27)21(10)2-3-22-16(24)18(20-17(22)25)13-5-11-4-12(7-13)8-14(18)6-11/h9,11-14H,2-8H2,1H3,(H,20,25)
InChIKeyYTQDCUMODKDTGZ-UHFFFAOYSA-N
XLogP1.85
TPSA110.37 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds4
Heavy Atoms27
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500373.41
LogP ≤ 51.85
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydantoin', 'substructure': 'N/A'}, {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 3'-[2-(2-methyl-5-nitroimidazol-1-yl)ethyl]spiro[adamantane-2,5'-imidazolidine]-2',4'-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3'-[2-(2-methyl-5-nitroimidazol-1-yl)ethyl]spiro[adamantane-2,5'-imidazolidine]-2',4'-dione?
The IUPAC name of 3'-[2-(2-methyl-5-nitroimidazol-1-yl)ethyl]spiro[adamantane-2,5'-imidazolidine]-2',4'-dione (CID 54526719) is 3'-[2-(2-methyl-5-nitroimidazol-1-yl)ethyl]spiro[adamantane-2,5'-imidazolidine]-2',4'-dione.
What is the SMILES notation for 3'-[2-(2-methyl-5-nitroimidazol-1-yl)ethyl]spiro[adamantane-2,5'-imidazolidine]-2',4'-dione?
The canonical SMILES for 3'-[2-(2-methyl-5-nitroimidazol-1-yl)ethyl]spiro[adamantane-2,5'-imidazolidine]-2',4'-dione is Cc1ncc([N+](=O)[O-])n1CCN1C(=O)NC2(C1=O)C1CC3CC(C1)CC2C3.
What is the InChIKey of 3'-[2-(2-methyl-5-nitroimidazol-1-yl)ethyl]spiro[adamantane-2,5'-imidazolidine]-2',4'-dione?
The InChIKey is YTQDCUMODKDTGZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H23N5O4/c1-10-19-9-15(23(26)27)21(10)2-3-22-16(24)18(20-17(22)25)13-5-11-4-12(7-13)8-14(18)6-11/h9,11-14H,2-8H2,1H3,(H,20,25).
What are the key properties of 3'-[2-(2-methyl-5-nitroimidazol-1-yl)ethyl]spiro[adamantane-2,5'-imidazolidine]-2',4'-dione?
3'-[2-(2-methyl-5-nitroimidazol-1-yl)ethyl]spiro[adamantane-2,5'-imidazolidine]-2',4'-dione has a molecular weight of 373.41 g/mol, XLogP of 1.85, 4 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 3'-[2-(2-methyl-5-nitroimidazol-1-yl)ethyl]spiro[adamantane-2,5'-imidazolidine]-2',4'-dione is sourced from PubChem (CID 54526719), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.